bioRxivPharmacology & Toxicology
A bead-based GPCR phosphorylation immunoassay for high-throughput ligand profiling and GRK inhibitor screening
J. Kaufmann, N. K. Blum, F. Nagel, A. S. Anna Schuler, J. Drube, C. Degenhart, J. Engel, J. E. Eickhoff, P. Dasgupta, S. Fritzwanker, M. Guastadisegni, C. Schulte, E. Miess-Tanneberg, H. M. Maric, M. Spetea, A. Kliewer, M. Baumann, B. Klebl, R. K. Reinscheid, C. Hoffmann, S. Schulz
Abstract
Analysis of agonist-driven phosphorylation of G protein-coupled receptors (GPCRs) can provide valuable insights into the receptor activation state and ligand pharmacology. However, to date, assessment of GPCR phosphorylation using high-throughput applications has been challenging. We have developed and validated a bead-based immunoassay for the quantitative assessment of agonist-induced GPCR phosphorylation that can be performed entirely in multiwell cell culture plates. The assay involves immunoprecipitation of affinity-tagged receptors using magnetic beads followed by protein detection using phosphorylation-state-specific and phosphorylation state-independent anti-GPCR antibodies. As proof of concept, five prototypical GPCRs (MOP, C5a1, D1, SST2, CB2) were treated with different agonists and antagonists, and concentration-response curves were generated. We then extended our approach to establish selective cellular GPCR kinase (GRK) inhibitor assays, which led to the rapid identification of a selective GRK5/6 inhibitor (LDC8988) and a highly potent pan-GRK inhibitor (LDC9728). In conclusion, this versatile GPCR phosphorylation assay can be used extensively for ligand profiling and inhibitor screening.
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- In situ visualization of opioid and cannabinoid drug effects using phosphosite-specific GPCR antibodies
S. Fritzwanker, F. Nagel, … S. Schulz·bioRxiv·Jun 14, 2022
- Single-molecule Dynamic In-Solution Inhibition Assay: A Method for Full Kinetic Profiling of Drug Candidate Binding to GPCRs in Native Membranes
T. P. Kaminski, V. P. Zhdanov, F. Hook·bioRxiv·Sep 16, 2021
- An accessible and generalizable in vitro luminescence assay for detecting GPCR activation
R. M. Miller, J. Sescil, … W. Wang·bioRxiv·Mar 2, 2023
- GRK2/3/5/6 knockout: The impact of individual GRKs on arrestin-binding and GPCR regulation
J. Drube, R. S. Haider, … C. Hoffmann·bioRxiv·Feb 12, 2021
- GRKs phosphorylate GPCR C-terminal peptides in a hierarchical manner
Arnelle Löbbert, Nils Lorz, … Alvar D. Gossert·bioRxiv·May 6, 2025
- Agonist-selective recruitment of engineered protein probes and of GRK2 by opioid receptors in living cells
M. Stoeber, D. Jullie, … M. von Zastrow·bioRxiv·Dec 5, 2019